Trial: 201908145

Randomized phase II/III study of venetoclax (ABT 199) plus chemoimmunotherapy for MYC/BCL2 double-hit and double-expressing lymphomas

Phase

II/III

Principal Investigator

Bartlett, Nancy

Disease Site

Non-Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov